Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-01-17
2006-01-17
Gambel, Phillip (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C530S388200, C530S388220, C530S388700, C530S388730, C435S326000, C435S332000, C435S334000, C435S343000, C435S343100, C435S343200, C435S346000
Reexamination Certificate
active
06987171
ABSTRACT:
The invention teaches human-compatible monoclonal antibodies which are specific against human CD28 and human T-lymphocytes of several to all sub-groups to activate without occupancy of an antigen receptor of the human T-lymphocytes and thus antigen-non-specifically.
REFERENCES:
patent: 5558864 (1996-09-01), Bendig et al.
patent: 5858358 (1999-01-01), June et al.
Siefken et al. Cell. Immnol. Feb. 1997; 176:59-65.
Tacke et al. Eur. J. Immunol. Jan. 1997; 27:239-247.
Gambel Phillip
Millen White Zelano & Branigan P.C.
Tegenero GmbH
LandOfFree
Human CD28 specific monoclonal antibodies for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human CD28 specific monoclonal antibodies for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human CD28 specific monoclonal antibodies for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3597304